CADILA HEALTHCARE Surges by 10%; BSE HEALTHCARE Index Up 4.5%
March 20, 2020 09:32 AM

CADILA HEALTHCARE share price has zoomed 10% and is presently trading at Rs 274.

Meanwhile, the BSE HEALTHCARE Index is at 11,925 (up 4.5%).

Among the top Gainers in the BSE HEALTHCARE Index today are CADILA HEALTHCARE (up 10.5%) and IPCA LABS (up 18.6%).

ERIS LIFESCIENCES LIMITED (down 1.5%) and SHILPA MEDICARE (down 5.0%) are among the top losers today.

Over the last one year, CADILA HEALTHCARE has moved down from Rs 337 to Rs 274, registering a loss of Rs 64 (down 19.5%).

On the other hand, the BSE HEALTHCARE has moved down from 14,270 to 11,925, loss of 2,345 points (down 16.5%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 86.7%), J.B.CHEMICALS (up 62.6%) and IPCA LABS (up 62.4%).

What About the Benchmark Indices?

The BSE Sensex is at 28,861 (up 1.7%).

The top gainers among the BSE Sensex stocks today are ONGC (up 5.5%), POWER GRID (up 5.5%) and BAJAJ AUTO (up 5.1%). Other gainers include HUL (up 5.1%) and ITC (up 5.0%). The most traded stocks in the BSE Sensex are SBI and ICICI BANK.

In the meantime, NSE Nifty is at 8,441 (up 0.3%). The top gainers in the NSE Nifty include GAIL (up 6.4%), POWER GRID (up 5.7%) and ONGC (up 4.8%). Other gainers include ITC (up 4.3%) and SUN PHARMA (up 4.2%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved down from 38,363 to 28,861, registering a loss of 9,502 points (down 25.04%).

CADILA HEALTHCARE Financial Update...

CADILA HEALTHCARE net profit down at Rs 4 billion for the quarter ended December 2019, compared to a loss of Rs 5 billion a year ago. Net Sales rose 1.7% to Rs 36.4 billion during the period as against Rs 35.8 billion in October-December 2018.

For the year ended March 2019, CADILA HEALTHCARE reported 4.8% increase in net profit to Rs 18.5 billion compared to net profit of Rs 17.7 billion during FY18.

Revenue of the company grew 10.1% to Rs 132 billion during FY19.

The current Price to earnings ratio of CADILA HEALTHCARE, based on rolling 12 month earnings, stands at 22.4x.